ET patients exhibited augmented levels of CCL2, CCL5, CXCL8, CXCL10, GM-CSF, IFN-γ, IL-1β, IL-17a, IL-18, TNF-α, and VEGF, when compared with CTRL. The gene discussed is CXCL10; the disease is essential thrombocythemia.